Mazen Hanna, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Mazen Hanna, MD

Mazen Hanna, MD

Healthcare Professional
Co-Director, Amyloid Program
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
Dr. Mazen Hanna is a cardiologist at the Cleveland Clinic, Ohio. He is the Director of the Heart Failure Intensive Care Unit and Co-Director of the Amyloid Program and is board certified in Internal Medicine, Cardiology, and Advanced Heart Failure and Transplant by the American Board of Internal Medicine. Dr. Hanna performs right and left heart catheterization as well as endomyocardial biopsy.
 
Dr. Hanna received his Bachelor of Arts degree from Cornell University in Ithaca, New York and Medical Degree from The Ohio State University and went on to do his Internal Medicine training at the Baylor College of Medicine in Houston, Texas where he received the Outstanding Medical Resident Teacher Award.  He came back to Cleveland to do his Cardiology Fellowship training at Case Western Reserve University, Metro Health Campus where he was appointed Chief Cardiovascular Fellow. He completed his training with a one year Advanced Fellowship in Heart Failure and Cardiac Transplantation at the Cleveland Clinic.   
 
Dr. Hanna has built strong clinical and research practices in amyloidosis at the Cleveland Clinic. His clinic treats both AL and ATTR amyloidosis and collaborates with specialists from other fields to provide thoughtful and comprehensive care. 
 
 
Representative Publications:
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close